Paycom Software, Inc. Reports Third Quarter 2021 Results
Paycom Software, Inc. (NYSE: PAYC) reported impressive Q3 2021 results with revenues of $256.2 million, a 30.4% increase from the prior year. GAAP net income reached $30.4 million or $0.52 per diluted share, while non-GAAP net income was $53.6 million, or $0.92 per diluted share. Adjusted EBITDA stood at $89.7 million, representing 35.0% of total revenues. The company reported cash and cash equivalents of $230.9 million and reduced net debt to $29.6 million. Guidance for Q4 projects revenues between $274.5 million and $276.5 million.
- Revenues of $256.2 million, up 30.4% YoY.
- GAAP net income increased to $30.4 million from $27.5 million YoY.
- Non-GAAP net income rose to $53.6 million from $40.6 million YoY.
- Adjusted EBITDA increased to $89.7 million from $67.5 million YoY.
- Cash and cash equivalents improved to $230.9 million.
- Total debt reduced to $29.6 million.
- None.
Third Quarter Revenues of
Third Quarter GAAP Net Income of
Third Quarter Non-GAAP Net Income of
Third Quarter Adjusted EBITDA of
“We delivered very strong third quarter results, which is a reflection of the investments we’ve made in product innovation, sales and marketing, and providing world-class service,” said Paycom’s founder and CEO,
Financial Highlights for the Third Quarter of 2021
Total Revenues of
GAAP Net Income was
Non-GAAP Net Income1 was
Adjusted EBITDA1 was
Cash and Cash Equivalents were
Total Debt, Net was
1 Adjusted EBITDA and non-GAAP net income are non-GAAP financial measures. Please see the discussion below under the heading "Use of Non-GAAP Financial Information" and the reconciliations at the end of this release for additional information concerning these and other non-GAAP financial measures.
Financial Outlook
Paycom provides the following expected financial guidance for the quarter and year ending
Quarter Ending
Total Revenues in the range of
Adjusted EBITDA in the range of
Year Ending
Total Revenues in the range of
Adjusted EBITDA in the range of
We have not reconciled the forward-looking adjusted EBITDA ranges presented above and discussed on the teleconference call to net income, nor the forward-looking adjusted EBITDA margins and forward-looking non-GAAP effective income tax rate discussed on the teleconference call to comparable GAAP measures, because applicable information for future periods, on which these reconciliations would be based, are not readily available due to uncertainty regarding, and the potential variability of, depreciation and amortization, interest expense, taxes, non-cash stock-based compensation expense, change in fair value of our interest rate swap and other items. Further, we have not reconciled the forward-looking adjusted gross margin range discussed on the teleconference call to GAAP gross margin because applicable information for future periods, on which this reconciliation would be based, is not readily available due to uncertainty regarding, and the potential variability of, cost of revenues, including non-cash stock-based compensation expense. Accordingly, reconciliations of the forward-looking adjusted EBITDA ranges to net income, the forward-looking adjusted EBITDA margins to net income margin, the forward-looking adjusted gross margin range to gross margin and the forward-looking non-GAAP effective income tax rate to the GAAP effective income tax rate are not available at this time without unreasonable effort. During the teleconference call, we also refer to a forward-looking estimate of our implied revenue growth plus adjusted EBITDA margin for 2021, or the “Rule of 60.” Because we are unable to reconcile forward-looking adjusted EBITDA margin to net income margin without unreasonable effort, we are unable to reconcile the “Rule of 60” to a comparable GAAP measure without unreasonable effort.
Impact of the COVID-19 Pandemic
During the third quarter of 2021, we transitioned the majority of our employees back to our offices, with a large contingent temporarily utilizing alternating schedules between work-from-home and on-site arrangements. We may take further actions that alter our business operations as may be required by federal, state or local authorities or that we determine are in the best interests of our employees and clients. Business continuity and safety will continue to guide our return-to-office plans. Although we currently have some insight with respect to the effects of the COVID-19 pandemic to date, it is not possible at this time to estimate the full impact that the crisis could continue to have on our business and results of operations.
- The COVID-19 pandemic has resulted in, and may continue to result in, headcount fluctuations across our client base. Because we charge our clients on a per-employee basis for certain services we provide, headcount fluctuations at our clients impacts our recurring revenue. The negative effects on our client revenue of lower headcount resulting from the pandemic were more than offset by headcount additions from new clients and modestly improved headcount levels among our pre-pandemic client base throughout the third quarter of 2021. We expect that our recurring revenue in future periods will continue to be impacted by such headcount fluctuations.
-
Despite growth in the number of clients in our base and growth in our average funds held for clients balance, significantly lower average interest rates during the first nine months of 2021 as compared to the first nine months of 2020 had a negative effect on interest earned on funds held for clients and, consequently, recurring revenue growth in the three and nine months ended
September 30, 2021 . - Our solution allows clients to seamlessly manage and communicate with their remote workforces. In a work-from-home environment, our clients have recognized the benefits of our focus on employee usage, as well as the strengths and advantages of our single database solution.
- While our sales force continues to conduct meetings with current and prospective clients virtually, as prospective clients begin to take meetings in-person, we expect our sales process would transition to include a combination of virtual and in-person meetings.
Use of Non-GAAP Financial Information
To supplement our financial information presented in accordance with generally accepted accounting principles in
The non-GAAP financial measures presented in this press release and discussed on the related teleconference call are not measures of financial performance under GAAP and should not be considered a substitute for net income, gross profit, gross margin, research and development expenses, sales and marketing expenses, administrative expenses and total research and development costs. Non-GAAP financial measures have limitations as analytical tools, and when assessing our operating performance, you should not consider these non-GAAP financial measures in isolation, or as a substitute for the consolidated statements of income data prepared in accordance with GAAP. The non-GAAP financial measures that we present may not be comparable to similarly titled measures of other companies and other companies may not calculate such measures in the same manner as we do.
Conference Call Details:
In conjunction with this announcement, Paycom will host a conference call today,
About Paycom
As a leader in payroll and HR technology,
Forward-Looking Statements
Certain statements in this press release are, and certain statements on the related teleconference call may be, forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are any statements that refer to Paycom’s estimated or anticipated results, other non-historical facts or future events and include, but are not limited to, statements regarding our business strategy; anticipated future operating results and operating expenses, cash flows, capital resources, dividends and liquidity; trends, opportunities and risks affecting our business, industry and financial results; future expansion or growth plans and potential for future growth; our ability to attract new clients to purchase our solution; our ability to retain clients and induce them to purchase additional applications; our ability to accurately forecast future revenues and appropriately plan our expenses; market acceptance of our solution and applications; our expectations regarding future revenues generated by certain applications; our ability to attract and retain qualified employees and key personnel; future regulatory, judicial and legislative changes; how certain factors affecting our performance correlate to improvement or deterioration in the labor market; our plan to open additional sales offices and our ability to effectively execute such plan; the sufficiency of our existing cash and cash equivalents to meet our working capital and capital expenditure needs over the next 12 months; our ability to relocate our
|
|
|||||||
Unaudited Consolidated Balance Sheets |
|
|||||||
(in thousands, except per share amounts) |
|
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
Assets |
|
|
|
|
|
|
|
|
Current assets: |
|
|
|
|
|
|
|
|
Cash and cash equivalents |
|
$ |
230,926 |
|
|
$ |
151,710 |
|
Accounts receivable |
|
|
13,004 |
|
|
|
9,130 |
|
Prepaid expenses |
|
|
26,643 |
|
|
|
17,854 |
|
Inventory |
|
|
866 |
|
|
|
1,151 |
|
Income tax receivable |
|
|
10,211 |
|
|
|
10,447 |
|
Deferred contract costs |
|
|
71,559 |
|
|
|
60,819 |
|
Current assets before funds held for clients |
|
|
353,209 |
|
|
|
251,111 |
|
Funds held for clients |
|
|
2,959,973 |
|
|
|
1,613,494 |
|
Total current assets |
|
|
3,313,182 |
|
|
|
1,864,605 |
|
Property and equipment, net |
|
|
329,296 |
|
|
|
285,218 |
|
Intangible assets, net |
|
|
59,057 |
|
|
|
319 |
|
|
|
|
51,889 |
|
|
|
51,889 |
|
Long-term deferred contract costs |
|
|
430,761 |
|
|
|
371,357 |
|
Other assets |
|
|
33,853 |
|
|
|
34,524 |
|
Total assets |
|
$ |
4,218,038 |
|
|
$ |
2,607,912 |
|
Liabilities and Stockholders’ Equity |
|
|
|
|
|
|
|
|
Current liabilities: |
|
|
|
|
|
|
|
|
Accounts payable |
|
$ |
9,441 |
|
|
$ |
6,787 |
|
Accrued commissions and bonuses |
|
|
12,431 |
|
|
|
13,703 |
|
Accrued payroll and vacation |
|
|
36,138 |
|
|
|
24,529 |
|
Deferred revenue |
|
|
16,175 |
|
|
|
13,567 |
|
Current portion of long-term debt |
|
|
1,775 |
|
|
|
1,775 |
|
Accrued expenses and other current liabilities |
|
|
50,340 |
|
|
|
44,175 |
|
Current liabilities before client funds obligation |
|
|
126,300 |
|
|
|
104,536 |
|
Client funds obligation |
|
|
2,959,973 |
|
|
|
1,613,494 |
|
Total current liabilities |
|
|
3,086,273 |
|
|
|
1,718,030 |
|
Deferred income tax liabilities, net |
|
|
125,228 |
|
|
|
112,598 |
|
Long-term deferred revenue |
|
|
81,702 |
|
|
|
73,259 |
|
Net long-term debt, less current portion |
|
|
27,815 |
|
|
|
29,119 |
|
Other long-term liabilities |
|
|
71,679 |
|
|
|
19,263 |
|
Total long-term liabilities |
|
|
306,424 |
|
|
|
234,239 |
|
Total liabilities |
|
|
3,392,697 |
|
|
|
1,952,269 |
|
Commitments and contingencies |
|
|
|
|
|
|
|
|
Stockholders’ equity: |
|
|
|
|
|
|
|
|
Common stock, |
|
|
622 |
|
|
|
618 |
|
Additional paid-in capital |
|
|
441,479 |
|
|
|
357,908 |
|
Retained earnings |
|
|
866,892 |
|
|
|
719,619 |
|
|
|
|
(483,652 |
) |
|
|
(422,502 |
) |
Total stockholders’ equity |
|
|
825,341 |
|
|
|
655,643 |
|
Total liabilities and stockholders’ equity |
|
$ |
4,218,038 |
|
|
$ |
2,607,912 |
|
|
|
|||||||||||||||
Unaudited Consolidated Statements of Income |
|
|||||||||||||||
(in thousands, except per share amounts)
|
|
|||||||||||||||
|
|
Three Months Ended |
|
|
Nine Months Ended |
|
||||||||||
|
|
|
2021 |
|
|
|
2020 |
|
|
|
2021 |
|
|
|
2020 |
|
Revenues |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Recurring |
|
$ |
251,306 |
|
|
$ |
192,664 |
|
|
$ |
756,665 |
|
|
$ |
609,109 |
|
Implementation and other |
|
|
4,888 |
|
|
|
3,868 |
|
|
|
13,873 |
|
|
|
11,378 |
|
Total revenues |
|
|
256,194 |
|
|
|
196,532 |
|
|
|
770,538 |
|
|
|
620,487 |
|
Cost of revenues |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating expenses |
|
|
34,766 |
|
|
|
24,278 |
|
|
|
92,612 |
|
|
|
71,651 |
|
Depreciation and amortization |
|
|
7,914 |
|
|
|
6,634 |
|
|
|
22,751 |
|
|
|
18,865 |
|
Total cost of revenues |
|
|
42,680 |
|
|
|
30,912 |
|
|
|
115,363 |
|
|
|
90,516 |
|
Administrative expenses |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sales and marketing |
|
|
69,745 |
|
|
|
62,146 |
|
|
|
200,485 |
|
|
|
173,228 |
|
Research and development |
|
|
31,077 |
|
|
|
21,772 |
|
|
|
84,012 |
|
|
|
65,171 |
|
General and administrative |
|
|
59,980 |
|
|
|
40,516 |
|
|
|
160,234 |
|
|
|
121,487 |
|
Depreciation and amortization |
|
|
9,407 |
|
|
|
7,150 |
|
|
|
25,503 |
|
|
|
20,209 |
|
Total administrative expenses |
|
|
170,209 |
|
|
|
131,584 |
|
|
|
470,234 |
|
|
|
380,095 |
|
Total operating expenses |
|
|
212,889 |
|
|
|
162,496 |
|
|
|
585,597 |
|
|
|
470,611 |
|
Operating income |
|
|
43,305 |
|
|
|
34,036 |
|
|
|
184,941 |
|
|
|
149,876 |
|
Interest expense |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(19 |
) |
Other income (expense), net |
|
|
244 |
|
|
|
246 |
|
|
|
1,019 |
|
|
|
(522 |
) |
Income before income taxes |
|
|
43,549 |
|
|
|
34,282 |
|
|
|
185,960 |
|
|
|
149,335 |
|
Provision for income taxes |
|
|
13,170 |
|
|
|
6,800 |
|
|
|
38,687 |
|
|
|
30,249 |
|
Net income |
|
$ |
30,379 |
|
|
$ |
27,482 |
|
|
$ |
147,273 |
|
|
$ |
119,086 |
|
Earnings per share, basic |
|
$ |
0.52 |
|
|
$ |
0.48 |
|
|
$ |
2.55 |
|
|
$ |
2.07 |
|
Earnings per share, diluted |
|
$ |
0.52 |
|
|
$ |
0.47 |
|
|
$ |
2.53 |
|
|
$ |
2.04 |
|
Weighted average shares outstanding: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic |
|
|
57,935 |
|
|
|
57,603 |
|
|
|
57,843 |
|
|
|
57,609 |
|
Diluted |
|
|
58,190 |
|
|
|
58,171 |
|
|
|
58,192 |
|
|
|
58,312 |
|
|
|
|||||||
Unaudited Consolidated Statements of Cash Flows |
|
|||||||
(in thousands) |
|
|||||||
|
|
Nine Months Ended |
|
|||||
|
|
2021 |
|
|
2020 |
|
||
Cash flows from operating activities |
|
|
|
|
|
|
|
|
Net income |
|
$ |
147,273 |
|
|
$ |
119,086 |
|
Adjustments to reconcile net income to net cash provided by operating activities: |
|
|
|
|
|
|
|
|
Depreciation and amortization |
|
|
48,254 |
|
|
|
39,073 |
|
Accretion of discount on available-for-sale securities |
|
|
(276 |
) |
|
|
(1,374 |
) |
Non-cash marketing expense |
|
|
618 |
|
|
|
— |
|
Loss on disposition of property and equipment |
|
|
146 |
|
|
|
— |
|
Amortization of debt issuance costs |
|
|
27 |
|
|
|
27 |
|
Stock-based compensation expense |
|
|
76,364 |
|
|
|
56,531 |
|
Cash paid for derivative settlement |
|
|
(558 |
) |
|
|
(424 |
) |
(Gain)/loss on derivative |
|
|
(305 |
) |
|
|
2,042 |
|
Deferred income taxes, net |
|
|
12,630 |
|
|
|
11,204 |
|
Changes in operating assets and liabilities: |
|
|
|
|
|
|
|
|
Accounts receivable |
|
|
(3,874 |
) |
|
|
(3,057 |
) |
Prepaid expenses |
|
|
(8,789 |
) |
|
|
(7,196 |
) |
Inventory |
|
|
97 |
|
|
|
32 |
|
Other assets |
|
|
671 |
|
|
|
(3,757 |
) |
Deferred contract costs |
|
|
(68,041 |
) |
|
|
(56,922 |
) |
Accounts payable |
|
|
1,659 |
|
|
|
4,491 |
|
Income taxes, net |
|
|
236 |
|
|
|
(5,260 |
) |
Accrued commissions and bonuses |
|
|
(1,272 |
) |
|
|
(4,403 |
) |
Accrued payroll and vacation |
|
|
11,609 |
|
|
|
12,853 |
|
Deferred revenue |
|
|
11,051 |
|
|
|
9,143 |
|
Accrued expenses and other current liabilities |
|
|
2,117 |
|
|
|
2,239 |
|
Net cash provided by operating activities |
|
|
229,637 |
|
|
|
174,328 |
|
Cash flows from investing activities |
|
|
|
|
|
|
|
|
Purchase of short-term investments from funds held for clients |
|
|
(170,760 |
) |
|
|
(217,858 |
) |
Proceeds from maturities of short-term investments from funds held for clients |
|
|
195,000 |
|
|
|
93,593 |
|
Purchases of intangible assets |
|
|
(1,500 |
) |
|
|
— |
|
Purchases of property and equipment |
|
|
(86,718 |
) |
|
|
(73,502 |
) |
Net cash used in investing activities |
|
|
(63,978 |
) |
|
|
(197,767 |
) |
Cash flows from financing activities |
|
|
|
|
|
|
|
|
Repurchases of common stock |
|
|
— |
|
|
|
(52,040 |
) |
Withholding taxes paid related to net share settlements |
|
|
(61,149 |
) |
|
|
(26,099 |
) |
Payments on long-term debt |
|
|
(1,331 |
) |
|
|
(1,331 |
) |
Net change in client funds obligation |
|
|
1,346,479 |
|
|
|
(140,421 |
) |
Net cash provided by (used in) financing activities |
|
|
1,283,999 |
|
|
|
(219,891 |
) |
Increase (decrease) in cash, cash equivalents, restricted cash and restricted cash equivalents |
|
|
1,449,658 |
|
|
|
(243,330 |
) |
Cash, cash equivalents, restricted cash and restricted cash equivalents |
|
|
|
|
|
|
|
|
Cash, cash equivalents, restricted cash and restricted cash equivalents, beginning of period |
|
|
1,585,275 |
|
|
|
1,641,854 |
|
Cash, cash equivalents, restricted cash and restricted cash equivalents, end of period |
|
$ |
3,034,933 |
|
|
$ |
1,398,524 |
|
|
|
|||||||
Unaudited Consolidated Statements of Cash Flows, continued |
|
|||||||
(in thousands) |
|
|||||||
|
|
Nine Months Ended |
|
|||||
|
|
2021 |
|
|
2020 |
|
||
Reconciliation of cash, cash equivalents, restricted cash and restricted cash equivalents |
|
|
|
|
|
|
|
|
Cash and cash equivalents |
|
$ |
230,926 |
|
|
$ |
156,398 |
|
Restricted cash included in funds held for clients |
|
|
2,804,007 |
|
|
|
1,242,126 |
|
Total cash, cash equivalents, restricted cash and restricted cash equivalents, end of period |
|
$ |
3,034,933 |
|
|
$ |
1,398,524 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Supplemental disclosures of cash flow information: |
|
|
|
|
|
|
|
|
Non-cash investing and financing activities: |
|
|
|
|
|
|
|
|
Purchases of property and equipment, accrued but not paid |
|
$ |
5,994 |
|
|
$ |
2,707 |
|
Stock-based compensation for capitalized software |
|
$ |
5,108 |
|
|
$ |
5,284 |
|
Right of use assets obtained in exchange for operating lease liabilities |
$ |
4,439 |
$ |
9,323 |
|
Unaudited Reconciliations of GAAP to Non-GAAP Financial Measures (in thousands, except per share amounts) |
||||||||||||||||
|
|
Three Months Ended |
|
|
Nine Months Ended |
|
||||||||||
|
|
2021 |
|
|
2020 |
|
|
2021 |
|
|
2020 |
|
||||
Net income to adjusted EBITDA: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income |
|
$ |
30,379 |
|
|
$ |
27,482 |
|
|
$ |
147,273 |
|
|
$ |
119,086 |
|
Interest expense |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
19 |
|
Provision for income taxes |
|
|
13,170 |
|
|
|
6,800 |
|
|
|
38,687 |
|
|
|
30,249 |
|
Depreciation and amortization |
|
|
17,321 |
|
|
|
13,784 |
|
|
|
48,254 |
|
|
|
39,074 |
|
EBITDA |
|
|
60,870 |
|
|
|
48,066 |
|
|
|
234,214 |
|
|
|
188,428 |
|
Non-cash stock-based compensation expense |
|
|
28,991 |
|
|
|
19,502 |
|
|
|
76,364 |
|
|
|
56,531 |
|
Change in fair value of interest rate swap |
|
|
(158 |
) |
|
|
(88 |
) |
|
|
(863 |
) |
|
|
1,618 |
|
Adjusted EBITDA |
|
$ |
89,703 |
|
|
$ |
67,480 |
|
|
$ |
309,715 |
|
|
$ |
246,577 |
|
Net income margin |
|
|
11.9 |
% |
|
|
14.0 |
% |
|
|
19.1 |
% |
|
|
19.2 |
% |
Adjusted EBITDA margin |
|
|
35.0 |
% |
|
|
34.3 |
% |
|
|
40.2 |
% |
|
|
39.7 |
% |
|
|
Three Months Ended |
|
|
Nine Months Ended |
|
||||||||||
|
|
2021 |
|
|
2020 |
|
|
2021 |
|
|
2020 |
|
||||
Net income to non-GAAP net income: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income |
|
$ |
30,379 |
|
|
$ |
27,482 |
|
|
$ |
147,273 |
|
|
$ |
119,086 |
|
Non-cash stock-based compensation expense |
|
|
28,991 |
|
|
|
19,502 |
|
|
|
76,364 |
|
|
|
56,531 |
|
Change in fair value of interest rate swap |
|
|
(158 |
) |
|
|
(88 |
) |
|
|
(863 |
) |
|
|
1,618 |
|
Income tax effect on non-GAAP adjustments |
|
|
(5,626 |
) |
|
|
(6,332 |
) |
|
|
(26,798 |
) |
|
|
(22,802 |
) |
Non-GAAP net income |
|
$ |
53,586 |
|
|
$ |
40,564 |
|
|
$ |
195,976 |
|
|
$ |
154,433 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average shares outstanding: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic |
|
|
57,935 |
|
|
|
57,603 |
|
|
|
57,843 |
|
|
|
57,609 |
|
Diluted |
|
|
58,190 |
|
|
|
58,171 |
|
|
|
58,192 |
|
|
|
58,312 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Earnings per share, basic |
|
$ |
0.52 |
|
|
$ |
0.48 |
|
|
$ |
2.55 |
|
|
$ |
2.07 |
|
Earnings per share, diluted |
|
$ |
0.52 |
|
|
$ |
0.47 |
|
|
$ |
2.53 |
|
|
$ |
2.04 |
|
Non-GAAP net income per share, basic |
|
$ |
0.92 |
|
|
$ |
0.70 |
|
|
$ |
3.39 |
|
|
$ |
2.68 |
|
Non-GAAP net income per share, diluted |
|
$ |
0.92 |
|
|
$ |
0.70 |
|
|
$ |
3.37 |
|
|
$ |
2.65 |
|
|
|
Three Months Ended |
|
|
Nine Months Ended |
|
||||||||||
|
|
2021 |
|
|
2020 |
|
|
2021 |
|
|
2020 |
|
||||
Earnings per share to non-GAAP net income per share, basic: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Earnings per share, basic |
|
$ |
0.52 |
|
|
$ |
0.48 |
|
|
$ |
2.55 |
|
|
$ |
2.07 |
|
Non-cash stock-based compensation expense |
|
|
0.50 |
|
|
|
0.34 |
|
|
|
1.32 |
|
|
|
0.98 |
|
Change in fair value of interest rate swap |
|
|
— |
|
|
|
— |
|
|
|
(0.01 |
) |
|
|
0.03 |
|
Income tax effect on non-GAAP adjustments |
|
|
(0.10 |
) |
|
|
(0.12 |
) |
|
|
(0.47 |
) |
|
|
(0.40 |
) |
Non-GAAP net income per share, basic |
|
$ |
0.92 |
|
|
$ |
0.70 |
|
|
$ |
3.39 |
|
|
$ |
2.68 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
Nine Months Ended |
|
||||||||||
|
|
2021 |
|
|
2020 |
|
|
2021 |
|
|
2020 |
|
||||
Earnings per share to non-GAAP net income per share, diluted: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Earnings per share, diluted |
|
$ |
0.52 |
|
|
$ |
0.47 |
|
|
$ |
2.53 |
|
|
$ |
2.04 |
|
Non-cash stock-based compensation expense |
|
|
0.50 |
|
|
|
0.34 |
|
|
|
1.31 |
|
|
|
0.97 |
|
Change in fair value of interest rate swap |
|
|
— |
|
|
|
— |
|
|
|
(0.01 |
) |
|
|
0.03 |
|
Income tax effect on non-GAAP adjustments |
|
|
(0.10 |
) |
|
|
(0.11 |
) |
|
|
(0.46 |
) |
|
|
(0.39 |
) |
Non-GAAP net income per share, diluted |
|
$ |
0.92 |
|
|
$ |
0.70 |
|
|
$ |
3.37 |
|
|
$ |
2.65 |
|
|
|
Three Months Ended |
|
|
Nine Months Ended |
|
||||||||||
|
|
2021 |
|
|
2020 |
|
|
2021 |
|
|
2020 |
|
||||
Adjusted gross profit: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total revenues |
|
$ |
256,194 |
|
|
$ |
196,532 |
|
|
$ |
770,538 |
|
|
$ |
620,487 |
|
Less: Total cost of revenues |
|
|
(42,680 |
) |
|
|
(30,912 |
) |
|
|
(115,363 |
) |
|
|
(90,516 |
) |
Total gross profit |
|
|
213,514 |
|
|
|
165,620 |
|
|
|
655,175 |
|
|
|
529,971 |
|
Plus: Non-cash stock-based compensation expense |
|
|
1,256 |
|
|
|
1,227 |
|
|
|
3,381 |
|
|
|
4,158 |
|
Total adjusted gross profit |
|
$ |
214,770 |
|
|
$ |
166,847 |
|
|
$ |
658,556 |
|
|
$ |
534,129 |
|
Gross margin |
|
|
83.3 |
% |
|
|
84.3 |
% |
|
|
85.0 |
% |
|
|
85.4 |
% |
Adjusted gross margin |
|
|
83.8 |
% |
|
|
84.9 |
% |
|
|
85.5 |
% |
|
|
86.1 |
% |
|
|
Three Months Ended |
|
|
Nine Months Ended |
|
||||||||||
|
|
2021 |
|
|
2020 |
|
|
2021 |
|
|
2020 |
|
||||
Adjusted sales and marketing expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sales and marketing expenses |
|
$ |
69,745 |
|
|
$ |
62,146 |
|
|
$ |
200,485 |
|
|
$ |
173,228 |
|
Less: Non-cash stock-based compensation expense |
|
|
(3,417 |
) |
|
|
(3,829 |
) |
|
|
(10,567 |
) |
|
|
(10,795 |
) |
Adjusted sales and marketing expenses |
|
$ |
66,328 |
|
|
$ |
58,317 |
|
|
$ |
189,918 |
|
|
$ |
162,433 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total revenues |
|
$ |
256,194 |
|
|
$ |
196,532 |
|
|
$ |
770,538 |
|
|
$ |
620,487 |
|
Sales and marketing expenses as a % of revenues |
|
|
27.2 |
% |
|
|
31.6 |
% |
|
|
26.0 |
% |
|
|
27.9 |
% |
Adjusted sales and marketing expenses as a % of revenues |
|
|
25.9 |
% |
|
|
29.7 |
% |
|
|
24.6 |
% |
|
|
26.2 |
% |
|
|
Three Months Ended |
|
|
Nine Months Ended |
|
||||||||||
|
|
2021 |
|
|
2020 |
|
|
2021 |
|
|
2020 |
|
||||
Adjusted total administrative expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total administrative expenses |
|
$ |
170,209 |
|
|
$ |
131,584 |
|
|
$ |
470,234 |
|
|
$ |
380,095 |
|
Less: Non-cash stock-based compensation expense |
|
|
(27,735 |
) |
|
|
(18,275 |
) |
|
|
(72,983 |
) |
|
|
(52,373 |
) |
Adjusted total administrative expenses |
|
$ |
142,474 |
|
|
$ |
113,309 |
|
|
$ |
397,251 |
|
|
$ |
327,722 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total revenues |
|
$ |
256,194 |
|
|
$ |
196,532 |
|
|
$ |
770,538 |
|
|
$ |
620,487 |
|
Total administrative expenses as a % of revenues |
|
|
66.4 |
% |
|
|
67.0 |
% |
|
|
61.0 |
% |
|
|
61.3 |
% |
Adjusted total administrative expenses as a % of revenues |
|
|
55.6 |
% |
|
|
57.7 |
% |
|
|
51.6 |
% |
|
|
52.8 |
% |
|
|
Three Months Ended |
|
|
Nine Months Ended |
|
||||||||||
|
|
2021 |
|
|
2020 |
|
|
2021 |
|
|
2020 |
|
||||
Adjusted research and development expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Research and development expenses |
|
$ |
31,077 |
|
|
$ |
21,772 |
|
|
$ |
84,012 |
|
|
$ |
65,171 |
|
Less: Non-cash stock-based compensation expense |
|
|
(1,827 |
) |
|
|
(2,115 |
) |
|
|
(5,394 |
) |
|
|
(7,270 |
) |
Adjusted research and development expenses |
|
$ |
29,250 |
|
|
$ |
19,657 |
|
|
$ |
78,618 |
|
|
$ |
57,901 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total revenues |
|
$ |
256,194 |
|
|
$ |
196,532 |
|
|
$ |
770,538 |
|
|
$ |
620,487 |
|
Research and development expenses as a % of revenues |
|
|
12.1 |
% |
|
|
11.1 |
% |
|
|
10.9 |
% |
|
|
10.5 |
% |
Adjusted research and development expenses as a % of revenues |
|
|
11.4 |
% |
|
|
10.0 |
% |
|
|
10.2 |
% |
|
|
9.3 |
% |
|
|
Three Months Ended |
|
|
Nine Months Ended |
|
||||||||||
|
|
2021 |
|
|
2020 |
|
|
2021 |
|
|
2020 |
|
||||
Total research and development costs: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Capitalized research and development costs |
|
$ |
13,157 |
|
|
$ |
11,727 |
|
|
$ |
39,160 |
|
|
$ |
32,448 |
|
Research and development expenses |
|
|
31,077 |
|
|
|
21,772 |
|
|
|
84,012 |
|
|
|
65,171 |
|
Total research and development costs |
|
$ |
44,234 |
|
|
$ |
33,499 |
|
|
$ |
123,172 |
|
|
$ |
97,619 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total revenues |
|
$ |
256,194 |
|
|
$ |
196,532 |
|
|
$ |
770,538 |
|
|
$ |
620,487 |
|
Total research and development costs as a % of revenues |
|
|
17.3 |
% |
|
|
17.0 |
% |
|
|
16.0 |
% |
|
|
15.7 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjusted total research and development costs: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total research and development costs |
|
$ |
44,234 |
|
|
$ |
33,499 |
|
|
$ |
123,172 |
|
|
$ |
97,619 |
|
Less: Capitalized non-cash stock-based compensation |
|
|
(1,757 |
) |
|
|
(1,566 |
) |
|
|
(5,108 |
) |
|
|
(5,284 |
) |
Less: Non-cash stock-based compensation expense |
|
|
(1,827 |
) |
|
|
(2,115 |
) |
|
|
(5,394 |
) |
|
|
(7,270 |
) |
Adjusted total research and development costs |
|
$ |
40,650 |
|
|
$ |
29,818 |
|
|
$ |
112,670 |
|
|
$ |
85,065 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total revenues |
|
$ |
256,194 |
|
|
$ |
196,532 |
|
|
$ |
770,538 |
|
|
$ |
620,487 |
|
Adjusted total research and development costs as a % of revenues |
15.9 |
% |
15.2 |
% |
14.6 |
% |
13.7 |
% |
Unaudited Components of Non-Cash Stock-Based Compensation Expense (in thousands) |
||||||||||||||||
|
|
Three Months Ended |
|
|
Nine Months Ended |
|
||||||||||
|
|
2021 |
|
|
2020 |
|
|
2021 |
|
|
2020 |
|
||||
Non-cash stock-based compensation expense: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating expenses |
|
$ |
1,256 |
|
|
$ |
1,227 |
|
|
$ |
3,381 |
|
|
$ |
4,158 |
|
Sales and marketing |
|
|
3,417 |
|
|
|
3,829 |
|
|
|
10,567 |
|
|
|
10,795 |
|
Research and development |
|
|
1,827 |
|
|
|
2,115 |
|
|
|
5,394 |
|
|
|
7,270 |
|
General and administrative |
|
|
22,491 |
|
|
|
12,331 |
|
|
|
57,022 |
|
|
|
34,308 |
|
Total non-cash stock-based compensation expense |
|
$ |
28,991 |
|
|
$ |
19,502 |
|
|
$ |
76,364 |
|
|
$ |
56,531 |
|
View source version on businesswire.com: https://www.businesswire.com/news/home/20211102006018/en/
Investor Relations Contact:
investors@paycom.com
Source:
FAQ
What were Paycom's Q3 2021 revenues?
How much did Paycom earn in net income for Q3 2021?
What is Paycom's guidance for Q4 2021 revenues?
What was Paycom's adjusted EBITDA in Q3 2021?